Please login to the form below

Not currently logged in
Email:
Password:

bioelectronics

This page shows the latest bioelectronics news and features for those working in and with pharma, biotech and healthcare.

Gilead and Verily team up to map inflammatory diseases

Gilead and Verily team up to map inflammatory diseases

The alliance with Gilead adds to Verily’s joint ventures with GSK, Galvani Bioelectronics and with Sanofi’s diabetes management platform Onduo.

Latest news

  • GSK and Google launch bioelectronics venture GSK and Google launch bioelectronics venture

    Bioelectronic medicine is concerned with the electrical signals firing between the body's nervous system and organs, working to regulate the faulty nerve impulses that occur in many illnesses. ... The UK pharma firm will own 55% of Galvani Bioelectronics,

  • Things can only get better Things can only get better

    For instance, bioelectronic medicine - an emerging technology - raises the prospect of implants being used to treat chronic conditions without the need for pills or injections.

  • Coming together Coming together

    Add to this areas like bioelectronics, which GSK is dabbling in, and we see the line between pharma and medtech becoming less clear than ever.

  • GSK expands bioelectronics efforts with $5m challenge fund GSK expands bioelectronics efforts with $5m challenge fund

    GlaxoSmithKline (GSK) is setting up a $5m fund for external researchers working in the area of bioelectronic medicines, boosting its investment in the emerging technology. ... The Bioelectronics Innovation Challenge set the task of developing a wireless

  • Pharma’s four options for innovation Pharma’s four options for innovation

    With bioelectronics GSK has placed a true bet on the future with little predictability of outcome. ... For instance GSK is investing in bioelectronics.

More from news
Approximately 5 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    There was the August announcement that Google's Verily company was investing in the development of bioelectronic medicines with GSK via the newly formed Galvani Bioelectronics.

  • Deal Watch August 2016 Deal Watch August 2016

    GSK had got the message back in 2012 when it set up a bioelectronics medicines group. ... GSK will hold 55% of the shares in Galvani Bioelectronics, which will seek to develop miniaturised devices, attached to individual nerves to correct irregular

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Medicxi appoints former GSK chair Moncef Slaoui Medicxi appoints former GSK chair Moncef Slaoui

    Dr Slaoui takes on the role alongside his other board positions, which include chairman of the board at Galvani Bioelectronics, and on the boards of Artisan Biosciences, Moderna Therapeutics and Sutovax.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics